Trial · NCT02415556
Results by group76
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 76
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Gait Speed Normal Walk (cm/s). | Type 2 Diabetes Mellitus - Insulin | Baseline | 112.23 | Standard Deviation 22.94 | cm/s |
| Gait Speed Normal Walk (cm/s). | Type 2 Diabetes Mellitus - Placebo | Baseline | 103.42 | Standard Deviation 21.04 | cm/s |
| Gait Speed Normal Walk (cm/s). | Control - Insulin | Baseline | 121.58 | Standard Deviation 21.87 | cm/s |
| Gait Speed Normal Walk (cm/s). | Control - Placebo | Baseline | 119.51 | Standard Deviation 15.61 | cm/s |
| Gait Speed Normal Walk (cm/s). | Type 2 Diabetes Mellitus - Insulin | On-treatment average | 112.43 | Standard Deviation 22.03 | cm/s |
| Gait Speed Normal Walk (cm/s). | Type 2 Diabetes Mellitus - Placebo | On-treatment average | 105.83 | Standard Deviation 21.27 | cm/s |
| Gait Speed Normal Walk (cm/s). | Control - Insulin | On-treatment average | 123.89 | Standard Deviation 23.36 | cm/s |
| Gait Speed Normal Walk (cm/s). | Control - Placebo | On-treatment average | 119.44 | Standard Deviation 18.60 | cm/s |
| Gait Speed Normal Walk (cm/s). | Type 2 Diabetes Mellitus - Insulin | Post-treatment average | 113.12 | Standard Deviation 19.60 | cm/s |
| Gait Speed Normal Walk (cm/s). | Type 2 Diabetes Mellitus - Placebo | Post-treatment average | 107.27 | Standard Deviation 23.16 | cm/s |
| Gait Speed Normal Walk (cm/s). | Control - Insulin | Post-treatment average | 124.79 | Standard Deviation 24.75 | cm/s |
| Gait Speed Normal Walk (cm/s). | Control - Placebo | Post-treatment average | 120.50 | Standard Deviation 19.33 | cm/s |
| Gait Speed Dual-task (cm/s). | Type 2 Diabetes Mellitus - Insulin | Baseline | 104.23 | Standard Deviation 23.30 | cm/s |
| Gait Speed Dual-task (cm/s). | Type 2 Diabetes Mellitus - Placebo | Baseline | 93.18 | Standard Deviation 22.71 | cm/s |
| Gait Speed Dual-task (cm/s). | Control - Insulin | Baseline | 109.44 | Standard Deviation 24.40 | cm/s |
| Gait Speed Dual-task (cm/s). | Control - Placebo | Baseline | 110.24 | Standard Deviation 16.50 | cm/s |
| Gait Speed Dual-task (cm/s). | Type 2 Diabetes Mellitus - Insulin | On-treatment average | 105.34 | Standard Deviation 23.59 | cm/s |
| Gait Speed Dual-task (cm/s). | Type 2 Diabetes Mellitus - Placebo | On-treatment average | 98.27 | Standard Deviation 22.39 | cm/s |
| Gait Speed Dual-task (cm/s). | Control - Insulin | On-treatment average | 114.66 | Standard Deviation 25.11 | cm/s |
| Gait Speed Dual-task (cm/s). | Control - Placebo | On-treatment average | 112.58 | Standard Deviation 17.99 | cm/s |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02415556/results